rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    AMIX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Autonomix Medical Granted New U.S. Patent Strengthening Proprietary Catheter-Based Sensing Technology
      Nov 10Yahoo FinanceAMIX
      Autonomix Medical, Inc. (AMIX) Receives a Buy from Maxim Group

      Tipranks Press Release.

      Oct 18The Globe and MailAMIX
      Autonomix secures Canadian patent for catheter-based technologies
      Oct 5Yahoo FinanceAMIX
      Autonomix receives Canadian patent for nerve therapy technology
      Oct 2Investing.comAMIX
      Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance
      Sep 30Yahoo FinanceAMIX
      Autonomix Medical receives European patent for neural assessment technology
      Sep 24Investing.comAMIX
      Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform
      Sep 24Yahoo FinanceAMIX
      Autonomix Medical appoints Sandra Cohen Kalter to board
      Sep 16Investing.comAMIX
      Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors

      Autonomix Medical, Inc. Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors Appointment adds more than four decades of MedTech leadership, FDA regulatory and strategic transaction experience, including work supporting renal denervation and other category-defining technologies THE WOODLANDS, TX, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to a

      Sep 16Yahoo FinanceAMIXMDT
      Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026

      Abstracts highlight potential of Autonomix’s transvascular technology across pain management and nervous system mapping THE WOODLANDS, TX, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that two scientific abstracts have been accepted for poster presentation at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2

      Sep 1Yahoo FinanceAMIX
      Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery

      New patent broadens protection around systems integrating real-time physiological feedback, sensing and imaging with controlled therapeutic delivery, including neural ablation approaches for cancer pain THE WOODLANDS, TX, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the issuance of U.S. Patent No. 12,714,780 by the United States Patent a

      Aug 26Yahoo FinanceAMIX
      12 Health Care Stocks Moving In Tuesday's Intraday Session
      Aug 25BenzingaAMIX
      12 Health Care Stocks Moving In Tuesday's Pre-Market Session
      Aug 25BenzingaAMIX
      Autonomix Medical Shares Surge Pre-Bell After $4.9 Million Warrant Inducement Priced at Premium to Market

      Autonomix Medical's (AMIX) shares jumped over 63% in premarket activity Tuesday after the company sa

      Aug 25Yahoo FinanceAMIX
      Autonomix Medical (AMIX) Stock Surges 117% After Hours: Here’s Why
      Aug 25BenzingaAMIX
      Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules

      THE WOODLANDS, TX, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced it has entered into a warrant inducement agreement with an investor (“Investor”) for the immediate exercise of certain outstanding warrants that the Company issued on July 15, 2026 (the “July 2026 Warrants”). Pursuant to a warrant inducement agreement, the Investor has agree

      Aug 25Yahoo FinanceAMIX
      12 Health Care Stocks Moving In Monday's After-Market Session
      Aug 24BenzingaAEMDAMIX

      This is the newest page. Registered accounts read further back.